Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
FUJI, Mar-Nov (Cumulative 3Q) Ordinary Profit Decreases by 18%, Sep-Nov Ordinary Profit Decreases by 35%
8278 FUJI CO., LTD. 【J-GAAP】
Earnings ReportFUJI CO., LTD. <8278> [TSE Prime] announced its financial results after the market closed on January 9th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending February 2025 (March to November) decreased 17.7% from the same period last year to 7.38 billion yen. The progress rate toward the full-year plan of 17.7 billion yen was 41.7%, also falling below the five-year average of 63.0%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the December to February period (4Q) is expected to grow 22.8% from the same period last year, reaching 10.3 billion yen.
In the most recent three-month period, from September to November (3Q), the consolidated ordinary profit dropped to 1.3 billion yen, a 35.0% decrease compared to the same period last year. The operating profit margin remained almost flat, changing from 0.6% in the same period last year to 0.5%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar - Nov, 2022 | 577,882 | 5,339 | 6,837 | 6,238 | 72.0 | 51.2 | Jan 12, 2023 | J-GAAP |
Mar - Nov, 2023 | 594,996 | 7,263 | 8,968 | 5,070 | 58.5 | 51.6 | Jan 10, 2024 | J-GAAP |
Mar - Nov, 2024 | 598,188 | 6,122 | 7,380 | 3,102 | 35.8 | 41.7 | Jan 9, 2025 | J-GAAP |
YoY | +0.5% | -15.7% | -17.7% | -38.8% | -38.8% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Sep - Feb, 2023 | 402,179 | 9,057 | 10,411 | 3,383 | 39.0 | 15 | Apr 8, 2024 | J-GAAP |
Sep - Feb, 2024 Guidance | 408,302 | 10,332 | 11,624 | 5,475 | 63.2 | 15 | Oct 7, 2024 | J-GAAP |
YoY | +1.5% | +14.1% | +11.7% | +61.8% | +61.9% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Feb, 2023 | 784,967 | 11,320 | 13,359 | 9,033 | 104.2 | 30 | Apr 12, 2023 | J-GAAP |
Feb, 2024 | 801,022 | 15,110 | 17,374 | 7,436 | 85.8 | 30 | Apr 8, 2024 | J-GAAP |
Feb, 2025 Guidance | 810,000 | 15,500 | 17,700 | 8,000 | 92.3 | 30 | Apr 8, 2024 | J-GAAP |
YoY | +1.1% | +2.6% | +1.9% | +7.6% | +7.6% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Sep - Nov, 2023 | 196,153 | 1,210 | 2,005 | 1,017 | 11.7 | 0.6 | Jan 10, 2024 | J-GAAP |
Dec - Feb, 2023 | 206,026 | 7,847 | 8,406 | 2,366 | 27.3 | 3.8 | Apr 8, 2024 | J-GAAP |
Mar - May, 2024 | 196,165 | 1,435 | 1,809 | 107 | 1.2 | 0.7 | Jul 8, 2024 | J-GAAP |
Jun - Aug, 2024 | 205,533 | 3,733 | 4,267 | 2,418 | 27.9 | 1.8 | Oct 7, 2024 | J-GAAP |
Sep - Nov, 2024 | 196,490 | 954 | 1,304 | 577 | 6.7 | 0.5 | Jan 9, 2025 | J-GAAP |
YoY | +0.2% | -21.2% | -35.0% | -43.3% | -43.2% |
Related Articles
HISAMITSU PHARMA, The Current Fiscal Year Ordinary Profit Revised Upward to an Unexpected 17% Increase
Sankyo Tateyama, The Current Fiscal Year Net Income Revised Downward by 87%
Daiwa, Mar-Nov (Cumulative 3Q) Ordinary Profit Decreases by 54%, Sep-Nov Ordinary Profit Turns to Loss
CAN DO, Mar-Nov (Cumulative 3Q) Ordinary Profit Increases by 32%, Sep-Nov Ordinary Profit Increases by 2.8 times
AEON Mall, Mar-Nov (Cumulative 3Q) Ordinary Profit Increases by 9%, Sep-Nov Ordinary Profit Increases by 11%
KANSEKI , Mar-Nov (Cumulative 3Q) Ordinary Profit Turns to Profit, Sep-Nov Ordinary Profit Turns to Profit
OSAKA ORGANIC CHEMICAL, 9% Increase in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 2 yen, This Fiscal Year to Increase Dividend by 2 yen
ARBEIT-TIMES, Mar-Nov (Cumulative 3Q) Ordinary Profit Decreases by 39%
OSG, 11% Increase in Ordinary Profit for The Current Fiscal Year
SANKO GOSEI, First Half Ordinary Profit Increases by 34%